{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-006648","form_type":"8-K","ticker":"PTN","cik":"0000911216","company_name":"PALATIN TECHNOLOGIES INC","filed_at":"2023-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.765348+00:00","generated_at":"2026-06-15T00:23:00.310229+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Palatin Q3 FY2023 net loss $7.1M; Vyleesi revenue up 453% YoY; Phase 3 dry eye data positive","bullets":["Net loss $7.1M ($0.63/share) vs $7.6M ($0.80) prior year; operating expenses $8.5M.","Vyleesi net product revenue $1.2M (+16% QoQ, +453% YoY); gross sales $3.4M (+165% YoY).","Phase 3 PL9643 dry eye lead-in (120 pts) showed statistical separation on signs/symptoms; final data expected H2 2023.","Cash $19.6M plus $1.7M receivables; expects to fund operations through CY2023.","Received $4.7M non-dilutive funding from NJ Economic Development Authority."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-006648","json":"https://secwatch.observer/filing/0001654954-23-006648.json","markdown":"https://secwatch.observer/filing/0001654954-23-006648.md","text":"https://secwatch.observer/filing/0001654954-23-006648.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/911216/000165495423006648/0001654954-23-006648-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/911216/000165495423006648/ptn_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T00:23:00.310229+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d54435b6a6cb62e6592fe401b904eb77391da2aa","claim":"PALATIN TECHNOLOGIES INC reported fiscal third quarter ended March 31, 2023 results: revenue net product revenue of $1.2 million.","evidence_excerpt":"For the fiscal third quarter ended March 31, 2023: – Gross product sales were $3.4 million, an increase of 31% over the prior quarter, and an increase of 165% over the comparable quarter last year. – Net product revenue of $1.2 million increased 16% over the prior quarter and increased 453% over the comparable quarter last year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/911216/000165495423006648/0001654954-23-006648-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal third quarter ended March 31, 2023"},{"label":"Revenue","value":"net product revenue of $1.2 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}